Latest animal models for anti-HIV drug discovery

Bibliography

• UNAIDS Gap report. Joint United Nations Programme on HIV/AIDS 2014. 2014. Available from: http://www.unaids.org/en/resources/campaigns/2014/2014gapreport/factsheet/ [Last accessed 4 September 2014]
   Google Scholar
• Rolland M, Edlefsen PT, Larsen BB, et al. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 2012;490:417-20
   PubMed Web of Science ®Google Scholar
• Korber B, Muldoon M, Theiler J, et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000;288:1789-96
   PubMed Web of Science ®Google Scholar
• Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71
   PubMed Web of Science ®Google Scholar
• Horsburgh CRJr, Holmberg SD. The global distribution of human immunodeficiency virus type 2 (HIV-2) infection. Transfusion 1988;28:192-5
   PubMed Web of Science ®Google Scholar
• Kirchhoff F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 2010;8:55-67
   PubMed Web of Science ®Google Scholar
• Freed EO. HIV-1 replication. Somat Cell Mol Genet 2001;26:13-33
   PubMedGoogle Scholar
• Chahroudi A, Bosinger SE, Vanderford TH, et al. Natural SIV hosts: showing AIDS the door. Science 2012;335:1188-93
   Web of Science ®Google Scholar
• Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000;287:607-14
   PubMed Web of Science ®Google Scholar
• Heeney JL, Dalgleish AG, Weiss RA. Origins of HIV and the evolution of resistance to AIDS. Science 2006;313:462-6
   PubMed Web of Science ®Google Scholar
• Miller RJ, Cairns JS, Bridges S, Sarver N. Human immunodeficiency virus and AIDS: insights from animal lentiviruses. J Virol 2000;74:7187-95
   PubMed Web of Science ®Google Scholar
• Torten M, Franchini M, Barlough JE, et al. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol 1991;65:2225-30
   PubMed Web of Science ®Google Scholar
• Hatziioannou T, Evans DT. Animal models for HIV/AIDS research. Nat Rev Microbiol 2012;10:852-67
   PubMed Web of Science ®Google Scholar
• Pedersen NC, Ho EW, Brown ML, Yamamoto JK. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987;235:790-3
   PubMed Web of Science ®Google Scholar
• Bienzle D. FIV in cats - a useful model of HIV in people? Vet Immunol Immunopathol 2014;159:171-9
   PubMed Web of Science ®Google Scholar
• Hong Y, Fink E, Hu QY, et al. OrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection. J Virol 2010;84:7225-32
   PubMed Web of Science ®Google Scholar
• Remington KM, Chesebro B, Wehrly K, et al. Mutants of feline immunodeficiency virus resistant to 3’-azido-3’-deoxythymidine. J Virol 1991;65:308-12
   PubMed Web of Science ®Google Scholar
• Egberink H, Borst M, Niphuis H, et al. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci USA 1990;87:3087-91
   PubMed Web of Science ®Google Scholar
• North TW, LaCasse RA. Testing anti-HIV drugs in the FIV model. Nat Med 1995;1:410-11
   PubMed Web of Science ®Google Scholar
• McDonnel SJ, Sparger EE, Murphy BG. Feline immunodeficiency virus latency. Retrovirology 2013;10:69
   PubMedGoogle Scholar
• Sparger EE. In vivo models of HIV disease and control. In: Friedman H, SSMB editor. Infectious diseases and pathogenesis. Springer; US: 2006. p. 149-237
   Google Scholar
• Asquith CR, Meli ML, Konstantinova LS, et al. Evaluation of the antiviral efficacy of bis[1,2]dithiolo[1,4]thiazines and bis[1,2]dithiolopyrrole derivatives against the nucelocapsid protein of the Feline Immunodeficiency Virus (FIV) as a model for HIV infection. Bioorg Med Chem Lett 2014;24:2640-4
   PubMed Web of Science ®Google Scholar
• Poli A, Tozon N, Guidi G, Pistello M. Renal alterations in feline immunodeficiency virus (FIV)-infected cats: a natural model of lentivirus-induced renal disease changes. Viruses 2012;4:1372-89
   PubMed Web of Science ®Google Scholar
• Pandrea I, Silvestri G, Onanga R, et al. Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: common patterns and species-specific differences. J Med Primatol 2006;35:194-201
   PubMed Web of Science ®Google Scholar
• Rey-Cuille MA, Berthier JL, Bomsel-Demontoy MC, et al. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 1998;72:3872-86
   PubMed Web of Science ®Google Scholar
• Weiss RA. Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges. Clin Exp Immunol 2008;152:201-10
   PubMed Web of Science ®Google Scholar
• Keele BF, Jones JH, Terio KA, et al. Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 2009;460:515-19
   PubMed Web of Science ®Google Scholar
• Girard M, Mahoney J, Wei Q, et al. Genital infection of female chimpanzees with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1998;14:1357-67
   PubMed Web of Science ®Google Scholar
• Murthy KK, Cobb EK, Rouse SR, et al. Correlates of protective immunity against HIV-1 infection in immunized chimpanzees. Immunol Lett 1996;51:121-4
   PubMed Web of Science ®Google Scholar
• Novembre FJ, Saucier M, Anderson DC, et al. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol 1997;71:4086-91
   PubMed Web of Science ®Google Scholar
• de Groot NG, Bontrop RE. The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind’s future? Retrovirology 2013;10:53
   PubMedGoogle Scholar
• Fultz PN, McClure HM, Swenson RB, et al. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol 1986;58:116-24
   PubMed Web of Science ®Google Scholar
• Fultz PN, McClure HM, Daugharty H, et al. Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis 1986;154:896-900
   PubMed Web of Science ®Google Scholar
• Fultz PN, Srinivasan A, Greene CR, et al. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J Virol 1987;61:4026-9
   PubMed Web of Science ®Google Scholar
• Fultz PN, Siegel RL, Brodie A, et al. Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1. J Infect Dis 1991;163:441-7
   PubMed Web of Science ®Google Scholar
• Johnson BK, Stone GA, Godec MS, et al. Long-term observations of human immunodeficiency virus-infected chimpanzees. AIDS Res Hum Retroviruses 1993;9:375-8
   PubMed Web of Science ®Google Scholar
• Joag SV. Primate models of AIDS. Microbes Infect 2000;2:223-9
   PubMed Web of Science ®Google Scholar
• European Union. Directive 2010/63/EU. Access to European Union law. 2010. Available from: http://eur-lex.europa.eu/legalcontent/EN/TXT/?uri=CELEX:32010L0063 [Last accessed 4 September 2014]
   Google Scholar
• Brehm MA, Jouvet N, Greiner DL, Shultz LD. Humanized mice for the study of infectious diseases. Curr Opin Immunol 2013;25:428-35
   PubMed Web of Science ®Google Scholar
• Altevogt BM, Pankevich DE, Shelton-Davenport MK. Chimpanzees in biomedical and behavioral research: assessing the necessity. National Academies Press (US); Washington (DC): 2011
   Google Scholar
• Kestler H, Kodama T, Ringler D, et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 1990;248:1109-12
   PubMed Web of Science ®Google Scholar
• Letvin NL, Daniel MD, Sehgal PK, et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985;230:71-3
   PubMed Web of Science ®Google Scholar
• Van Rompay KK. Evaluation of antiretrovirals in animal models of HIV infection. Antiviral Res 2010;85:159-75
   PubMed Web of Science ®Google Scholar
• Daniel MD, Letvin NL, King NW, et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985;228:1201-4
   PubMed Web of Science ®Google Scholar
• Evans DT, Silvestri G. Nonhuman primate models in AIDS research. Curr Opin HIV AIDS 2013;8:255-61
   PubMed Web of Science ®Google Scholar
• Wyand MS. The use of SIV-infected rhesus monkeys for the preclinical evaluation of AIDS drugs and vaccines. AIDS Res Hum Retroviruses 1992;8:349-56
   PubMed Web of Science ®Google Scholar
• Klatt NR, Canary LA, Sun X, et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J Clin Invest 2013;123:903-7
   PubMed Web of Science ®Google Scholar
• Heneine W, Kashuba A. HIV prevention by oral preexposure prophylaxis. Cold Spring Harb Perspect Med 2012;2:a007419
   PubMed Web of Science ®Google Scholar
• Deere JD, Schinazi RF, North TW. Simian immunodeficiency virus macaque models of HIV latency. Curr Opin HIV AIDS 2011;6:57-61
   PubMedGoogle Scholar
• Clements JE, Gama L, Graham DR, et al. A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system. Curr Opin HIV AIDS 2011;6:37-42
   PubMed Web of Science ®Google Scholar
• Ambrose Z, KewalRamani VN, Bieniasz PD, Hatziioannou T. HIV/AIDS: in search of an animal model. Trends Biotechnol 2007;25:333-7
   PubMed Web of Science ®Google Scholar
• Kinman L, Brodie SJ, Tsai CC, et al. Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaques. J Acquir Immune Defic Syndr 2003;34:387-97
   PubMed Web of Science ®Google Scholar
• Riddick NE, Hermann EA, Loftin LM, et al. A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog 2010;6:e1001064
   PubMedGoogle Scholar
• Veazey RS, Ketas TJ, Dufour J, et al. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor. J Infect Dis 2010;202:739-44
   PubMed Web of Science ®Google Scholar
• Williams R, Bokhari S, Silverstein P, et al. Nonhuman primate models of NeuroAIDS. J Neurovirol 2008;14:292-300
   PubMed Web of Science ®Google Scholar
• Uberla K, Stahl-Hennig C, Bottiger D, et al. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci USA 1995;92:8210-14
   PubMed Web of Science ®Google Scholar
• Haigwood NL. Update on animal models for HIV research. Eur J Immunol 2009;39:1994-9
   PubMed Web of Science ®Google Scholar
• Joag SV, Li Z, Foresman L, et al. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol 1996;70:3189-97
   PubMed Web of Science ®Google Scholar
• North TW, Van Rompay KK, Higgins J, et al. Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. J Virol 2005;79:7349-54
   PubMed Web of Science ®Google Scholar
• Kamada K, Igarashi T, Martin MA, et al. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc Natl Acad Sci USA 2006;103:16959-64
   PubMed Web of Science ®Google Scholar
• Hatziioannou T, Princiotta M, Piatak MJr, et al. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 2006;314:95
   PubMed Web of Science ®Google Scholar
• Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008;451:425-30
   PubMed Web of Science ®Google Scholar
• Goldstone DC, Ennis-Adeniran V, Hedden JJ, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011;480:379-82
   PubMed Web of Science ®Google Scholar
• Stremlau M, Owens CM, Perron MJ, et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004;427:848-53
   PubMed Web of Science ®Google Scholar
• Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002;418:646-50
   PubMed Web of Science ®Google Scholar
• Saito A, Akari H. Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors. Front Microbiol 2013;4:187
   PubMed Web of Science ®Google Scholar
• Hatziioannou T, Del Prete GQ, Keele BF, et al. HIV-1-induced AIDS in monkeys. Science 2014;344:1401-5
   PubMed Web of Science ®Google Scholar
• Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 1995;270:1197-9
   PubMed Web of Science ®Google Scholar
• Van Rompay KK. Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments. AIDS Rev 2005;7:67-83
   PubMed Web of Science ®Google Scholar
• Morrow WJ, Wharton M, Lau D, Levy JA. Small animals are not susceptible to human immunodeficiency virus infection. J Gen Virol 1987;68(Pt 8):2253-7
   PubMedGoogle Scholar
• Filice G, Cereda PM, Orsolini P, et al. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1. Microbiologica 1990;13:215-24
   PubMed Web of Science ®Google Scholar
• Keppler OT, Welte FJ, Ngo TA, et al. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med 2002;195:719-36
   PubMed Web of Science ®Google Scholar
• Michel N, Goffinet C, Ganter K, et al. Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo. Retrovirology 2009;6:2
   PubMed Web of Science ®Google Scholar
• Takayanagi R, Ohashi T, Yamashita E, et al. Enhanced replication of human T-cell leukemia virus type 1 in T cells from transgenic rats expressing human CRM1 that is regulated in a natural manner. J Virol 2007;81:5908-18
   PubMed Web of Science ®Google Scholar
• Hatziioannou T, Bieniasz PD. Antiretroviral restriction factors. Curr Opin Virol 2011;1:526-32
   PubMed Web of Science ®Google Scholar
• Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983;301:527-30
   PubMed Web of Science ®Google Scholar
• Namikawa R, Kaneshima H, Lieberman M, et al. Infection of the SCID-hu mouse by HIV-1. Science 1988;242:1684-6
   PubMed Web of Science ®Google Scholar
• McCune JM, Namikawa R, Kaneshima H, et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241:1632-9
   PubMed Web of Science ®Google Scholar
• Fraser CC, Kaneshima H, Hansteen G, et al. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft. Blood 1995;86:1680-93
   PubMed Web of Science ®Google Scholar
• Kaneshima H, Shih CC, Namikawa R, et al. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc Natl Acad Sci USA 1991;88:4523-7
   PubMed Web of Science ®Google Scholar
• McCune JM. Animal models of HIV-1 disease. Science 1997;278:2141-2
   PubMed Web of Science ®Google Scholar
• McCune JM. Development and applications of the SCID-hu mouse model. Semin Immunol 1996;8:187-96
   PubMedGoogle Scholar
• McCune JM, Namikawa R, Shih CC, et al. Suppression of HIV infection in AZT-treated SCID-hu mice. Science 1990;247:564-6
   PubMed Web of Science ®Google Scholar
• Shih CC, Kaneshima H, Rabin L, et al. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis 1991;163:625-7
   PubMed Web of Science ®Google Scholar
• Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256-9
   PubMed Web of Science ®Google Scholar
• Mosier DE, Gulizia RJ, Baird SM, et al. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 1991;251:791-4
   PubMed Web of Science ®Google Scholar
• Mosier DE, Gulizia RJ, MacIsaac PD, et al. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc Natl Acad Sci USA 1993;90:2443-7
   PubMed Web of Science ®Google Scholar
• Mosier DE. Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. Adv Immunol 1996;63:79-125
   PubMed Web of Science ®Google Scholar
• Mosier DE, Gulizia RJ, Baird SM, et al. Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol 1989;152:195-9
   PubMed Web of Science ®Google Scholar
• Berges BK, Wheat WH, Palmer BE, et al. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology 2006;3:76
   PubMed Web of Science ®Google Scholar
• Tary-Lehmann M, Lehmann PV, Schols D, et al. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras. J Exp Med 1994;180:1817-27
   PubMed Web of Science ®Google Scholar
• Hoffmann-Fezer G, Gall C, Zengerle U, et al. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 1993;81:3440-8
   PubMed Web of Science ®Google Scholar
• Namikawa R, Weilbaecher KN, Kaneshima H, et al. Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 1990;172:1055-63
   PubMed Web of Science ®Google Scholar
• Pettoello-Mantovani M, Kollmann TR, Raker C, et al. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. Antimicrob Agents Chemother 1997;41:1880-7
   PubMed Web of Science ®Google Scholar
• Stoddart CA, Bales CA, Bare JC, et al. Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals. PLoS One 2007;2:e655
   PubMed Web of Science ®Google Scholar
• Rabin L, Hincenbergs M, Moreno MB, et al. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob Agents Chemother 1996;40:755-62
   PubMed Web of Science ®Google Scholar
• Lapidot T, Pflumio F, Doedens M, et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992;255:1137-41
   PubMed Web of Science ®Google Scholar
• Greiner DL, Hesselton RA, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells 1998;16:166-77
   PubMed Web of Science ®Google Scholar
• Zhang L, Su L. HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol 2012;9:237-44
   PubMed Web of Science ®Google Scholar
• Brehm MA, Shultz LD, Greiner DL. Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 2010;17:120-5
   PubMed Web of Science ®Google Scholar
• D’Cruz OJ, Uckun FM. Limitations of the human-PBL-SCID mouse model for vaginal transmission of HIV-1. Am J Reprod Immunol 2007;57:353-60
   PubMed Web of Science ®Google Scholar
• Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 2007;7:118-30
   PubMed Web of Science ®Google Scholar
• Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995;154:180-91
   PubMed Web of Science ®Google Scholar
• Prochazka M, Gaskins HR, Shultz LD, Leiter EH. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 1992;89:3290-4
   PubMed Web of Science ®Google Scholar
• Shultz LD, Lyons BL, Burzenski LM, et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005;174:6477-89
   PubMed Web of Science ®Google Scholar
• Watanabe S, Terashima K, Ohta S, et al. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007;109:212-18
   PubMed Web of Science ®Google Scholar
• Dash PK, Gorantla S, Gendelman HE, et al. Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci 2011;31:3148-57
   PubMed Web of Science ®Google Scholar
• Gorantla S, Poluektova L, Gendelman HE. Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci 2012;35:197-208
   PubMed Web of Science ®Google Scholar
• Balazs AB, Ouyang Y, Hong CM, et al. Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission. Nat Med 2014;20:296-300
   PubMed Web of Science ®Google Scholar
• Nischang M, Sutmuller R, Gers-Huber G, et al. Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1. PLoS One 2012;7:e38853
   PubMed Web of Science ®Google Scholar
• Dash PK, Gendelman HE, Roy U, et al. Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. Aids 2012;26:2135-44
   PubMed Web of Science ®Google Scholar
• Hur EM, Patel SN, Shimizu S, et al. Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood 2012;120:4571-82
   PubMed Web of Science ®Google Scholar
• Melkus MW, Estes JD, Padgett-Thomas A, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006;12:1316-22
   PubMed Web of Science ®Google Scholar
• Wege AK, Melkus MW, Denton PW, et al. Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 2008;324:149-65
   PubMed Web of Science ®Google Scholar
• Rongvaux A, Takizawa H, Strowig T, et al. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol 2013;31:635-74
   PubMed Web of Science ®Google Scholar
• Denton PW, Krisko JF, Powell DA, et al. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One 2010;5:e8829
   PubMed Web of Science ®Google Scholar
• Denton PW, Othieno F, Martinez-Torres F, et al. One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J Virol 2011;85:7582-93
   PubMed Web of Science ®Google Scholar
• Abdool KQ, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-74
   PubMed Web of Science ®Google Scholar
• Wahl A, Swanson MD, Nochi T, et al. Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice. PLoS Pathog 2012;8:e1002732
   PubMedGoogle Scholar
• Schatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell 1989;59:1035-48
   PubMed Web of Science ®Google Scholar
• Shinkai Y, Rathbun G, Lam KP, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992;68:855-67
   PubMed Web of Science ®Google Scholar
• Shultz LD, Pearson T, King M, et al. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research. Ann N Y Acad Sci 2007;1103:77-89
   PubMed Web of Science ®Google Scholar
• Brehm MA, Cuthbert A, Yang C, et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol 2010;135:84-98
   PubMed Web of Science ®Google Scholar
• Choudhary SK, Rezk NL, Ince WL, et al. Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse. J Virol 2009;83:8254-8
   PubMed Web of Science ®Google Scholar
• Nischang M, Gers-Huber G, Audige A, et al. Modeling HIV infection and therapies in humanized mice. Swiss Med Wkly 2012;142:w13618
   PubMed Web of Science ®Google Scholar
• Sango K, Joseph A, Patel M, et al. Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice. AIDS Res Hum Retroviruses 2010;26:735-46
   PubMed Web of Science ®Google Scholar
• Centlivre M, Legrand N, Klamer S, et al. Preclinical in vivo evaluation of the safety of a multi-shRNA-based gene therapy against HIV-1. Mol Ther Nucleic Acids 2013;2:e120
   PubMedGoogle Scholar
• Van DR, Cardenas J, Easley R, et al. Effect of transcription peptide inhibitors on HIV-1 replication. Virology 2008;376:308-22
   PubMed Web of Science ®Google Scholar
• Neff CP, Ndolo T, Tandon A, et al. Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model. PLoS One 2010;5:e15257
   PubMed Web of Science ®Google Scholar
• de Graaf CA, Metcalf D. Thrombopoietin and hematopoietic stem cells. Cell Cycle 2011;10:1582-9
   PubMed Web of Science ®Google Scholar
• Rongvaux A, Willinger T, Takizawa H, et al. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc Natl Acad Sci USA 2011;108:2378-83
   PubMed Web of Science ®Google Scholar
• Willinger T, Rongvaux A, Takizawa H, et al. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci USA 2011;108:2390-5
   PubMed Web of Science ®Google Scholar
• Ito R, Takahashi T, Katano I, Ito M. Current advances in humanized mouse models. Cell Mol Immunol 2012;9:208-14
   PubMed Web of Science ®Google Scholar
• Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004;304:104-7
   PubMed Web of Science ®Google Scholar
• King MA, Covassin L, Brehm MA, et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009;157:104-18
   PubMed Web of Science ®Google Scholar
• Buchner SM, Sliva K, Bonig H, et al. Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells. Clin Exp Immunol 2013;173:355-64
   PubMed Web of Science ®Google Scholar
• Hayward SL, Bautista-Lopez N, Suzuki K, et al. CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice. J Immunol 2006;176:7715-25
   PubMed Web of Science ®Google Scholar
• Cosgrove D, Gray D, Dierich A, et al. Mice lacking MHC class II molecules. Cell 1991;66:1051-66
   PubMedGoogle Scholar
• Nabozny GH, Baisch JM, Cheng S, et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 1996;183:27-37
   PubMed Web of Science ®Google Scholar
• Denton PW, Garcia JV. Humanized mouse models of HIV infection. AIDS Rev 2011;13:135-48
   PubMed Web of Science ®Google Scholar